Details

Autor(en) / Beteiligte

• Spalenkova, Alzbeta
• Ehrlichova, Marie
• Seborova, Karolina
• Vaclavikova, Radka
• Balatka, Stepan
• Soucek, Pavel

Titel

EP037/#733 The effect of 7-ketocholesterol on breast carcinoma cell lines treated with tamoxifen in vitro

Ist Teil von

• International journal of gynecological cancer, 2022-12, Vol.32 (Suppl 3), p.A63-A63

Ort / Verlag

Oxford: BMJ Publishing Group Ltd

Erscheinungsjahr

2022

Beschreibungen/Notizen

• ObjectivesOxysterols are oxidative derivatives of cholesterol that play many roles in human physiology and pathology, including cancer. For example, oxysterols modulate cell proliferation, apoptosis, or migration. This study aimed to analyze the role of important oxysterol, 7-ketocholesterol (7-KC), in response of breast carcinoma cell line models to treatment with tamoxifen.MethodsTwo estrogen receptor (ER) positive (MCF-7 and T47D) and one ER-negative (BT-20) breast carcinoma cell lines were employed. Cell lines were co-incubated with tamoxifen and 7-KC at different concentration ratios, and the viability of cells, proliferation, cell cycle, caspase activity, and gene expression changes were evaluated. Next, the ability of 7-KC to stimulate cell migration and invasivity was tested.Results7-KC slightly increased the IC50 value of tamoxifen in the MCF7 cell line, but decreased it in the BT-20 cell line. No significant difference was observed for T47D cells. In line with these data, caspase 3/7 activity was enhanced by 7-KC in BT-20 cells, but not in any ER-positive cell line. Gene expression analysis showed upregulation of tamoxifen metabolizing genes, e.g. CYP1A1 and CYP1B1 in MCF-7 while downregulation in BT-20 cells. Finally, we found that the presence of 7-KC potentiates cellular migration and invasivity.Conclusions7-KC seems to modulate the response of breast carcinoma cells to tamoxifen according to ER status in vitro, making it an interesting candidate for future studies. The study was supported by projects INTER-ACTION no. LTAUSA19032 and AZV no. NU20–09–00174.